Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000015 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 23, 2026 |
| Document Date | Jan 23, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
383,400
Total Value
$0.00
P&L
+inf% (+$15,838,254.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 23, 2026 | Grant/Award | 76,700 | $0.00 | $0.00 | 929,038 | Direct | โ | View Details | |
Director | Employee Stock Option (right to buy) | Derivative | Jan 23, 2026 | Grant/Award | 306,700 | $0.00 | $0.00 | 306,700 | Direct | โ | View Details |